Tenepla Tablet is an oral anti-diabetic medicine manufactured by Cipla Ltd. It contains Teneligliptin 20mg, a DPP-4 (Dipeptidyl Peptidase-4) inhibitor, which is prescribed for the management of Type 2 Diabetes Mellitus. It helps improve blood sugar control in adults, especially when diet, exercise, or other medicines alone are not sufficient.
By enhancing the activity of incretin hormones, Teneligliptin increases insulin release and decreases excess glucose production by the liver. This results in better fasting and postprandial (after-meal) sugar control, while reducing the risk of hypoglycemia compared to some other antidiabetic agents.
How Tenepla Works
-
Teneligliptin (20mg): Inhibits the enzyme DPP-4, which prolongs the action of incretin hormones (GLP-1 and GIP).
-
This leads to:
-
Increased insulin secretion in response to meals.
-
Decreased glucagon secretion, reducing excess glucose release by the liver.
-
Provides balanced glucose control without significant weight gain.
Uses of Tenepla Tablet
-
Treatment of Type 2 Diabetes Mellitus in adults.
-
Helps reduce both fasting and post-meal blood sugar levels.
-
Can be used as monotherapy (alone) or in combination with other antidiabetic drugs such as Metformin, Sulfonylureas, or Insulin.
-
Aims to lower the risk of diabetes-related complications like kidney damage, nerve issues, heart disease, and eye damage.
Dosage & Administration
-
Recommended dose: 20mg once daily (as prescribed by the doctor).
-
Can be taken with or without food.
-
Regular monitoring of blood glucose and HbA1c is essential.
Precautions
-
Not for Type 1 Diabetes or diabetic ketoacidosis.
-
Use cautiously in patients with kidney or liver impairment (dose adjustment may be needed).
-
Pregnant or breastfeeding women should use only if prescribed by a doctor.
-
Avoid excessive alcohol consumption.
Possible Side Effects
-
Headache, dizziness
-
Mild hypoglycemia (when combined with other diabetes medicines)
-
Constipation or abdominal discomfort
-
Nasopharyngitis (sore throat, runny nose)
-
Rare: allergic reactions, liver enzyme elevation
Overall Benefit
Tenepla Tablet offers effective and safe glycemic control for patients with Type 2 Diabetes. With its once-daily dosing, low risk of hypoglycemia, and weight-neutral profile, it is a convenient choice for long-term diabetes management.
Tenepla-M 1000 Tablet is an oral antidiabetic combination medicine manufactured by Cipla Ltd. It is prescribed for the management of Type 2 Diabetes Mellitus when diet, exercise, and monotherapy do not provide adequate control.
It combines:
-
Teneligliptin (20mg): A DPP-4 inhibitor that enhances incretin hormones (GLP-1 and GIP). This results in increased insulin release from the pancreas and reduced glucagon secretion, especially after meals, thereby lowering blood glucose levels.
-
Metformin (1000mg): A biguanide that reduces glucose production in the liver, improves insulin sensitivity, and slows down glucose absorption from the intestine.
This dual mechanism ensures effective control of fasting blood glucose (FPG) and postprandial blood glucose (PPG), leading to improved HbA1c outcomes.
Uses of Tenepla-M 1000 Tablet
-
Management of Type 2 Diabetes Mellitus in adults.
-
Improves both short-term and long-term glycemic control.
-
Helps prevent complications of diabetes such as kidney damage, nerve damage, vision problems, and cardiovascular diseases.
-
Suitable for patients requiring stronger glycemic control compared to lower Metformin doses.
How Tenepla-M 1000 Works
-
Teneligliptin (20mg): Prolongs the action of incretin hormones, which stimulate insulin secretion in a glucose-dependent manner and suppress glucagon release.
-
Metformin (1000mg): Reduces hepatic glucose output, enhances peripheral glucose uptake, and decreases intestinal absorption of glucose.
Together, they provide complementary action for stable and effective blood sugar management.
Dosage & Administration
-
Usually taken once or twice daily, as directed by the physician.
-
Best taken with meals to reduce gastrointestinal side effects from Metformin.
-
Regular monitoring of blood sugar and HbA1c is advised.
Precautions
-
Not for use in Type 1 Diabetes Mellitus or diabetic ketoacidosis.
-
Should be used cautiously in patients with kidney or liver problems.
-
Avoid alcohol as it increases the risk of lactic acidosis (rare but serious).
-
Not recommended in severe heart failure.
-
Use in pregnancy and breastfeeding should be under medical supervision.
Possible Side Effects
-
Nausea, vomiting, abdominal discomfort, diarrhea (commonly due to Metformin)
-
Headache, dizziness
-
Hypoglycemia (especially if combined with other antidiabetic agents)
-
Sore throat, mild infections (nasopharyngitis)
-
Rare: Lactic acidosis, liver enzyme changes, allergic reactions
Overall Benefit
Tenepla-M 1000 Tablet is an effective combination therapy for Type 2 Diabetes, especially for patients who need stronger sugar control. By combining Teneligliptin and a higher dose of Metformin, it helps maintain stable glucose levels, reduces long-term complications, and improves overall quality of life.
Tenepla-M 500 Tablet is a combination oral antidiabetic medicine manufactured by Cipla Ltd. It contains two active ingredients:
-
Teneligliptin (20mg): A DPP-4 inhibitor that enhances incretin hormones, helping the pancreas release more insulin and reducing excessive glucose production in the liver.
-
Metformin (500mg): A biguanide that lowers sugar levels by reducing hepatic glucose production, improving insulin sensitivity, and slowing intestinal glucose absorption.
This dual action provides better glycemic control compared to monotherapy and helps manage Type 2 Diabetes Mellitus effectively.
Uses of Tenepla-M 500 Tablet
-
Treatment of Type 2 Diabetes Mellitus in adults.
-
Improves control of both fasting blood glucose (FPG) and postprandial glucose (PPG).
-
Reduces the risk of long-term diabetes complications such as kidney disease, neuropathy, retinopathy, and cardiovascular events.
-
Suitable when diet, exercise, or single drug therapy alone is not sufficient.
How Tenepla-M 500 Works
-
Teneligliptin (20mg): Blocks the DPP-4 enzyme, prolonging incretin action (GLP-1 & GIP), which increases insulin secretion and lowers glucagon release after meals.
-
Metformin (500mg): Decreases liver glucose output, increases peripheral glucose utilization, and reduces gut glucose absorption.
Together, they provide complementary mechanisms for optimal sugar control.
Dosage & Administration
-
Usually taken once or twice daily, as prescribed by the doctor.
-
Should be taken with meals to minimize gastrointestinal side effects.
-
Regular monitoring of blood sugar and HbA1c is recommended.
Precautions
-
Not suitable for Type 1 Diabetes or diabetic ketoacidosis.
-
Use cautiously in patients with kidney or liver impairment (dose adjustment may be required).
-
Avoid in cases of severe heart failure, lactic acidosis, or heavy alcohol consumption.
-
Pregnant and breastfeeding women should use only under medical supervision.
Possible Side Effects
-
Nausea, vomiting, diarrhea, abdominal pain (mostly due to Metformin)
-
Headache, dizziness
-
Hypoglycemia (more likely if combined with other antidiabetic agents)
-
Sore throat, mild infections (nasopharyngitis)
-
Rare: Lactic acidosis (serious but uncommon), liver enzyme changes, allergic reactions
Overall Benefit
Tenepla-M 500 Tablet is a powerful and convenient combination therapy for Type 2 Diabetes. It helps maintain long-term glycemic control, reduces diabetes-related complications, and provides the benefit of dual action with a low risk of hypoglycemia and weight neutrality.
Tenlimac 20 mg Tablet is an oral antidiabetic medication containing Teneligliptin, which belongs to the class of DPP-4 inhibitors. It works by enhancing the body’s own ability to lower blood sugar by increasing insulin release and decreasing glucagon levels after meals. This helps achieve better glycemic control in patients with type 2 diabetes mellitus.
Uses
Tenlimac 20 mg Tablet is prescribed for:
-
Management of type 2 diabetes mellitus
-
As monotherapy or in combination with other antidiabetic agents (like metformin)
-
Improving postprandial and fasting blood glucose levels
-
Supporting long-term glycemic control
Advantages
-
Effective blood sugar control in type 2 diabetes
-
Low risk of hypoglycemia when used alone
-
Once-daily dosing improves patient compliance
-
Can be combined with other oral antidiabetic drugs or insulin for enhanced effect
Possible Side Effects
Common side effects:
Rare but serious side effects:
-
Allergic reactions (rash, swelling, itching)
-
Severe hypoglycemia (especially when combined with other antidiabetic agents)
-
Pancreatitis (rare)
Precautions
-
Take exactly as prescribed, preferably at the same time daily
-
Monitor blood sugar regularly
-
Inform your doctor if you have kidney or liver disease
-
Not recommended for type 1 diabetes or diabetic ketoacidosis
-
Report any unusual abdominal pain or allergic reactions immediately
Tenlimac M 1000 Tablet SR is a combination oral antidiabetic medication containing Metformin and Teneligliptin.
-
Metformin (1000mg): A biguanide that reduces hepatic glucose production and improves insulin sensitivity, helping to lower blood sugar levels.
-
Teneligliptin (20mg): A DPP-4 inhibitor that enhances insulin secretion and reduces glucagon release after meals, supporting better glycemic control.
This combination provides dual-action blood sugar control, suitable for patients not adequately controlled by monotherapy. The SR (sustained release) formulation ensures stable plasma drug levels and reduces gastrointestinal side effects.
Uses
Tenlimac M 1000 Tablet SR is prescribed for:
-
Management of type 2 diabetes mellitus
-
Patients not controlled by Metformin or Teneligliptin alone
-
Improving fasting and postprandial blood glucose levels
-
Long-term glycemic control and diabetes management
Advantages
-
Dual mechanism of action for enhanced blood sugar control
-
Sustained-release formulation reduces gastrointestinal discomfort
-
Can be used as monotherapy or in combination with other antidiabetic agents
-
Convenient once-daily dosing improves patient compliance
Possible Side Effects
Common side effects:
Rare but serious side effects:
-
Lactic acidosis (rare, more likely in kidney or liver dysfunction)
-
Severe hypoglycemia (when combined with other antidiabetic drugs)
-
Pancreatitis (rare)
Precautions
-
Take as prescribed, preferably with meals to reduce gastrointestinal side effects
-
Regularly monitor blood sugar levels
-
Inform your doctor if you have kidney, liver, or heart disease
-
Not recommended for type 1 diabetes or diabetic ketoacidosis
-
Seek medical attention for unusual abdominal pain or signs of hypoglycemia
Tenlimac M 500 Tablet SR is a combination oral antidiabetic medication containing Metformin and Teneligliptin.
-
Metformin (500mg): A biguanide that reduces glucose production in the liver and improves insulin sensitivity, lowering blood sugar levels.
-
Teneligliptin (20mg): A DPP-4 inhibitor that enhances insulin secretion and reduces glucagon release after meals, improving glycemic control.
The SR (sustained-release) formulation provides stable plasma drug levels, reduces gastrointestinal side effects, and allows for once-daily dosing.
Uses
Tenlimac M 500 Tablet SR is prescribed for:
-
Management of type 2 diabetes mellitus
-
Patients not adequately controlled by Metformin or Teneligliptin alone
-
Improving fasting and postprandial blood glucose
-
Long-term glycemic control
Advantages
-
Dual mechanism of action for enhanced blood sugar control
-
Sustained-release formulation reduces gastrointestinal discomfort
-
Can be used as monotherapy or in combination with other antidiabetic agents
-
Convenient once-daily dosing improves patient compliance
Possible Side Effects
Common side effects:
Rare but serious side effects:
-
Lactic acidosis (rare, especially in kidney or liver impairment)
-
Severe hypoglycemia (when combined with other antidiabetic drugs)
-
Pancreatitis (rare)
Precautions
-
Take as prescribed, preferably with meals to reduce gastrointestinal side effects
-
Regularly monitor blood sugar levels
-
Inform your doctor if you have kidney, liver, or heart disease
-
Not suitable for type 1 diabetes or diabetic ketoacidosis
-
Seek medical attention for unusual abdominal pain or signs of hypoglycemia